Daré Bioscience Reports First Quarter 2019 Financial Results and Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Dare Bioscience (DARE) Tops Q1 EPS by 3c
May 14, 2019 4:01 PM EDTDare Bioscience (NASDAQ: DARE) reported Q1 EPS of ($0.27), $0.03 better than the analyst estimate of ($0.30).
The first quarter was an active one for Daré and positioned us well for the year ahead, said Sabrina Martucci Johnson, President and CEO of Daré. We believe our differentiated product... More
